Skip to main content

Table 1 Demographic and clinical characteristics

From: Tumor infiltrating B-cells are increased in prostate cancer tissue

  ALL (n = 53)
Mean age ± SD, years 62 ± 6.8
 Race  
 Caucasian 45 (84.9%)
Other 8 (15.1%)
Mean BMI ± SD, Kg/m2 27.7 ± 3.6
Hypertension 13 (24.5%)
Hypercholesterolemia 15 (28.3%)
Diabetes 5 (9.4%)
Coronary artery disease 4 (7.5%)
5 Alpha-Reductase (Proscar/Avodart) 8 (15.1%)
Primary relative with prostate Ca 17 (32.1%)
Median PSA (IQR), ng/mL 6.2 (4.2–9.8)
Clinical T stage  
 T1a-c 24 (45.3%)
 T2a-c 25 (47.2%)
 T3a-b 4 (7.5%)
Biopsy Gleason score  
 ≤ 6 20 (37.7%)
 7 17 (32.1%)
 ≥ 8 16 (30.2%)
D'Amico risk group  
 Low risk 10 (16.7%)
 Intermediate risk 9 (15.0%)
 High risk 15 (25%)
 Recurrence 26 (43.3%)